logo
Plus   Neg
Share
Email

CASI Pharmaceuticals Inc. (CASI) Is Up Sharply On Manufacturing Deal

CASI Pharmaceuticals Inc. (CASI) announced Thursday morning that it has entered into a strategic and long-term manufacturing agreement with Yiling Wanzhou International Pharmaceutical for entecavir and cilostazol.

CASI Pharmaceuticals gapped open sharply higher Thursday, but has pared its gains in early trade. Shares are still up 1.10 at $6.80 on above average volume. The stock has jumped to nearly a 1-month high.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT
>